FDA grants Humanitarian Device Exemption for OncoSil, the first Class III device delivering targeted P-32 microparticles for distal bile duct cancer.
Welcome to Advanced Practice Corner
A space created exclusively for advanced practice providers in oncology. Here, you’ll find a wealth of resources tailored to your needs, including insightful articles, event information, a comprehensive resource guide, and educational videos.
Our mission is to support your vital role in cancer care by providing the latest advances in therapy options, adverse effect management, and patient communication strategies. This is your hub for the tools and knowledge to enhance your expertise and empower your practice.
Latest News
Advertisement
Oncology clinical trial nurse navigator Elise Curry, RN, explains the impact of the FDA's approval of oral iberdomide for multiple myeloma.
A meta-analysis shows traditional pathology counts fail to predict which patients benefit from adding hormone therapy to postoperative radiation.
The FDA granted accelerated approval to iberdomide with daratumumab and dexamethasone for relapsed/refractory multiple myeloma.
Oncology social worker Kelly Dyckman, LCSW, shares key strategies for identifying patient distress, demystifying counseling, and managing trauma.
